Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Baptist Health South Florida
- Study ID
- NCT05756985
- Status
- Recruiting
Conditions
- Glioblastoma
- Glioblastoma Multiforme
- Gliosarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Specimen Collection — PROCEDURECollect and preserve glioblastoma tissue for exploratory analyses to generate hypotheses for future studies.
Study Details
To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.
Key Dates
- Start date
- Dec 11, 2024
- Status verified
- Jan 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 120 participants (estimated)
Arms
- Arm: GlioblastomaSurgical tumor resection as standard of care and specimen collection
Primary Outcome Measure
Number of glioblastoma (GBM) samples for analysis [ Time Frame: 2 years ]
Central Contacts
- Manmeet S Ahluwalia, M.D.(786) 596-2000
- Michael McDermott, M.D.(786) 596-2000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Miami Cancer Institute at Baptist Health, Inc. | Miami | Florida | 33176 |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2/PHASE3 · Recruiting · Global Coalition for Adaptive Research · Birmingham, Alabama
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama